Similarly, high PDGFRβ tumor stromal expression significantly correlated with more aggressive clinical behavior in patients with breast cancer, including high histopathological grade, estrogen receptor negativity, high HER2 expression and shorter survival[24]. This evidence concerns the gene ERBB2 and neoplasm.